LONDON — The global antiseptics and disinfectants market in 2009 was at about $3.4 billion, and with a 12 percent increase, sales reached about $3.8 billion in 2010, according to a press release.
Market growth has accelerated in recent years following large scale outbreaks of several infectious diseases, such as methicillin-resistant Staphylococcus aureus (MRSA), avian flu and swine flu (H1N1), the release stated.
According to the release, the market is expected to rise at a compound annual growth rate (CAGR) of 11.1 percent and reach $7.1 billion by 2016.
The U.S. constituted approximately 41 percent of the total antiseptics and disinfectants market in 2010 and was around $1.5 billion; this is expected to increase to nearly $2.9 billion by 2016 at a CAGR of 11 percent, the release noted.
Europe contributed to about 34 percent of the total market and was $1.3 billion in 2010 and has reached $1.4 billion in 2011; this is expected to grow at a CAGR of 11.2 percent and reach $2.4 billion by 2016, the release added.
Click here to read the complete release.